Ephedrine Alkaloid Serious AEs Consistent With Background Levels - Industry
This article was originally published in The Tan Sheet
Executive Summary
An estimated incidence of stroke among ephedrine alkaloid dietary supplement users of 7.1 per 100,000 patient-years falls within background rates ranging from three to 60 per 100,000, an industry rep told a Public Health Service panel Aug. 8.
You may also be interested in...
Ephedra Marketing, Availability Debated At Government Reform Hearing
FDA's Center for Food Safety & Applied Nutrition has reached a standoff with industry over how best to regulate ephedrine alkaloid-containing dietary supplements, CFSAN Director Joseph Levitt stated during a House Government Reform Committee hearing on supplement regulation March 20.
Ephedra Marketing, Availability Debated At Government Reform Hearing
FDA's Center for Food Safety & Applied Nutrition has reached a standoff with industry over how best to regulate ephedrine alkaloid-containing dietary supplements, CFSAN Director Joseph Levitt stated during a House Government Reform Committee hearing on supplement regulation March 20.
Ephedra Marketing, Availability Debated At Government Reform Hearing
FDA's Center for Food Safety & Applied Nutrition has reached a standoff with industry over how best to regulate ephedrine alkaloid-containing dietary supplements, CFSAN Director Joseph Levitt stated during a House Government Reform Committee hearing on supplement regulation March 20.